Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

NYSE:ALB - New York Stock Exchange, Inc. - US0126531013 - Common Stock - Currency: USD

62.75  -2.33 (-3.58%)

Fundamental Rating

3

Taking everything into account, ALB scores 3 out of 10 in our fundamental rating. ALB was compared to 85 industry peers in the Chemicals industry. ALB may be in some trouble as it scores bad on both profitability and health. ALB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALB has reported negative net income.
In the past year ALB had a positive cash flow from operations.
Of the past 5 years ALB 4 years were profitable.
Each year in the past 5 years ALB had a positive operating cash flow.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of -7.69%, ALB is doing worse than 74.12% of the companies in the same industry.
ALB has a worse Return On Equity (-13.04%) than 71.76% of its industry peers.
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

With a Gross Margin value of 3.53%, ALB is not doing good in the industry: 87.06% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ALB has declined.
ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALB has been increased compared to 5 years ago.
The debt/assets ratio for ALB has been reduced compared to a year ago.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ALB has an Altman-Z score of 1.47. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.47, ALB is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.31 indicates that ALB is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.31, ALB is doing good in the industry, outperforming 74.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACCN/A
WACC8.32%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.11 indicates that ALB has no problem at all paying its short term obligations.
The Current ratio of ALB (2.11) is comparable to the rest of the industry.
A Quick Ratio of 1.26 indicates that ALB should not have too much problems paying its short term obligations.
ALB has a Quick ratio (1.26) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.26
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The earnings per share for ALB have decreased strongly by -122.82% in the last year.
The Revenue for ALB has decreased by -39.34% in the past year. This is quite bad
The Revenue has been growing by 8.42% on average over the past years. This is quite good.
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%

3.2 Future

The Earnings Per Share is expected to grow by 63.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALB will show a quite strong growth in Revenue. The Revenue will grow by 13.04% on average per year.
EPS Next Y37.37%
EPS Next 2Y55.59%
EPS Next 3Y58.33%
EPS Next 5Y63.97%
Revenue Next Year-11.2%
Revenue Next 2Y-0.9%
Revenue Next 3Y4.94%
Revenue Next 5Y13.04%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALB. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 63.73 indicates a quite expensive valuation of ALB.
ALB's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALB is more expensive than 71.76% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.40, ALB is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 63.73
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALB is valued a bit more expensive than the industry average as 78.82% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 62.47
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

ALB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ALB's earnings are expected to grow with 58.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.59%
EPS Next 3Y58.33%

6

5. Dividend

5.1 Amount

ALB has a Yearly Dividend Yield of 2.76%.
ALB's Dividend Yield is a higher than the industry average which is at 3.75.
ALB's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 2.76%

5.2 History

On average, the dividend of ALB grows each year by 13.04%, which is quite nice.
ALB has paid a dividend for at least 10 years, which is a reliable track record.
ALB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.04%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of ALB are negative and hence is the payout ratio. ALB will probably not be able to sustain this dividend level.
ALB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-27.05%
EPS Next 2Y55.59%
EPS Next 3Y58.33%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ALBEMARLE CORP

NYSE:ALB (6/12/2025, 2:41:49 PM)

62.75

-2.33 (-3.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners99.62%
Inst Owner Change-1.1%
Ins Owners0.22%
Ins Owner Change15.29%
Market Cap7.38B
Analysts69.38
Price Target83.1 (32.43%)
Short Float %16.08%
Short Ratio5.21
Dividend
Industry RankSector Rank
Dividend Yield 2.76%
Yearly Dividend2.65
Dividend Growth(5Y)13.04%
DP-27.05%
Div Incr Years30
Div Non Decr Years30
Ex-Date06-13 2025-06-13 (0.405)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-54.53%
Max EPS beat(2)69.72%
EPS beat(4)1
Avg EPS beat(4)-81.09%
Min EPS beat(4)-249.28%
Max EPS beat(4)69.72%
EPS beat(8)3
Avg EPS beat(8)-26.81%
EPS beat(12)7
Avg EPS beat(12)-12.91%
EPS beat(16)11
Avg EPS beat(16)-4.32%
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-7.88%
Revenue beat(4)1
Avg Revenue beat(4)-3.24%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)5.88%
Revenue beat(8)3
Avg Revenue beat(8)-1.95%
Revenue beat(12)3
Avg Revenue beat(12)-2.81%
Revenue beat(16)5
Avg Revenue beat(16)-1.38%
PT rev (1m)-1.05%
PT rev (3m)-16.88%
EPS NQ rev (1m)-13.08%
EPS NQ rev (3m)-167.86%
EPS NY rev (1m)-9.19%
EPS NY rev (3m)-210.75%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-2.29%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-4.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 63.73
P/S 1.45
P/FCF N/A
P/OCF 6.42
P/B 0.74
P/tB 0.9
EV/EBITDA 62.47
EPS(TTM)-2.78
EYN/A
EPS(NY)0.98
Fwd EY1.57%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)9.77
OCFY15.57%
SpS43.29
BVpS85.23
TBVpS69.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.53%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 20.2
Cap/Depr 205.72%
Cap/Sales 25.31%
Interest Coverage N/A
Cash Conversion 742.04%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.26
Altman-Z 1.47
F-Score4
WACC8.32%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
EPS Next Y37.37%
EPS Next 2Y55.59%
EPS Next 3Y58.33%
EPS Next 5Y63.97%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%
Revenue Next Year-11.2%
Revenue Next 2Y-0.9%
Revenue Next 3Y4.94%
Revenue Next 5Y13.04%
EBIT growth 1Y40.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.87%
EBIT Next 3Y44.72%
EBIT Next 5Y38.95%
FCF growth 1Y-114.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.55%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%